Literature DB >> 20033799

Successful post-remission therapy with a combination of all-trans retinoic acid and arsenic trioxide in an elderly Japanese patient newly diagnosed with acute promyelocytic leukemia.

Yujin Kobayashi, Yoshihiro Hatta, Hikari Ishizuka, Yukio Hirabayashi, Toshitake Tanaka, Kazuhiro Takei, Jin Takeuchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20033799     DOI： 10.1007/s12185-009-0470-7

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  11 in total

Review 1.  Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission.

Authors:  J Zhu; V Lallemand-Breitenbach; H de Thé
Journal:  Oncogene       Date:  2001-10-29       Impact factor: 9.867

2.  Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia.

Authors:  Elihu Estey; Guillermo Garcia-Manero; Alessandra Ferrajoli; Stefan Faderl; Srdan Verstovsek; Dan Jones; Hagop Kantarjian
Journal:  Blood       Date:  2005-12-22       Impact factor: 22.113

3.  Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide.

Authors:  W Y Au; C S Chim; A K W Lie; R Liang; Y L Kwong
Journal:  Br J Haematol       Date:  2002-04       Impact factor: 6.998

4.  United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia.

Authors:  S L Soignet; S R Frankel; D Douer; M S Tallman; H Kantarjian; E Calleja; R M Stone; M Kalaycio; D A Scheinberg; P Steinherz; E L Sievers; S Coutré; S Dahlberg; R Ellison; R P Warrell
Journal:  J Clin Oncol       Date:  2001-09-15       Impact factor: 44.544

5.  Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity.

Authors:  Vikram Mathews; Biju George; Kavitha M Lakshmi; Auro Viswabandya; Ashish Bajel; Poonkuzhali Balasubramanian; Ramachandran Velayudhan Shaji; Vivi M Srivastava; Alok Srivastava; Mammen Chandy
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

6.  Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy.

Authors:  A Ghavamzadeh; K Alimoghaddam; S H Ghaffari; S Rostami; M Jahani; R Hosseini; A Mossavi; E Baybordi; A Khodabadeh; M Iravani; B Bahar; Y Mortazavi; M Totonchi; N Aghdami
Journal:  Ann Oncol       Date:  2005-10-14       Impact factor: 32.976

7.  Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin.

Authors:  Farhad Ravandi; Eli Estey; Dan Jones; Stefan Faderl; Susan O'Brien; Jackie Fiorentino; Sherry Pierce; Deborah Blamble; Zeev Estrov; William Wierda; Alessandra Ferrajoli; Srdan Verstovsek; Guillermo Garcia-Manero; Jorge Cortes; Hagop Kantarjian
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

Review 8.  Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

Authors:  Miguel A Sanz; David Grimwade; Martin S Tallman; Bob Lowenberg; Pierre Fenaux; Elihu H Estey; Tomoki Naoe; Eva Lengfelder; Thomas Büchner; Hartmut Döhner; Alan K Burnett; Francesco Lo-Coco
Journal:  Blood       Date:  2008-09-23       Impact factor: 22.113

Review 9.  An efficient therapeutic approach to patients with acute promyelocytic leukemia using a combination of arsenic trioxide with low-dose all-trans retinoic acid.

Authors:  Guanjun Wang; Wei Li; Jiuwei Cui; Sujun Gao; Cheng Yao; Zhenyu Jiang; Yanqiu Song; Chang-Ji Yuan; Yan Yang; Ziling Liu; Lu Cai
Journal:  Hematol Oncol       Date:  2004-06       Impact factor: 5.271

10.  All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia.

Authors:  Zhi-Xiang Shen; Zhan-Zhong Shi; Jing Fang; Bai-Wei Gu; Jun-Min Li; Yong-Mei Zhu; Jing-Yi Shi; Pei-Zheng Zheng; Hua Yan; Yuan-Fang Liu; Yu Chen; Yang Shen; Wen Wu; Wei Tang; Samuel Waxman; Hugues De Thé; Zhen-Yi Wang; Sai-Juan Chen; Zhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-24       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.